2010
DOI: 10.1093/nar/gkq704
|View full text |Cite
|
Sign up to set email alerts
|

TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain

Abstract: DNA double-strand breaks enhance homologous recombination in cells and have been exploited for targeted genome editing through use of engineered endonucleases. Here we report the creation and initial characterization of a group of rare-cutting, site-specific DNA nucleases produced by fusion of the restriction enzyme FokI endonuclease domain (FN) with the high-specificity DNA-binding domains of AvrXa7 and PthXo1. AvrXa7 and PthXo1 are members of the transcription activator-like (TAL) effector family whose centr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
318
0
6

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 478 publications
(326 citation statements)
references
References 47 publications
(84 reference statements)
2
318
0
6
Order By: Relevance
“…S everal types of highly specific DNA recognition and cleavage enzymes, including homing endonucleases (HEs), zinc finger nucleases (ZFNs), and transcription activator-like (TAL) effector nucleases, are being developed for targeted gene modification, ranging from gene disruption to corrective gene therapy (1)(2)(3)(4)(5). Regardless of the identity of the protein scaffold, site-specific gene modification generally requires the creation of individually tailored site-specific endonucleases that generate double-strand breaks (DSBs) at unique chromosomal targets.…”
mentioning
confidence: 99%
“…S everal types of highly specific DNA recognition and cleavage enzymes, including homing endonucleases (HEs), zinc finger nucleases (ZFNs), and transcription activator-like (TAL) effector nucleases, are being developed for targeted gene modification, ranging from gene disruption to corrective gene therapy (1)(2)(3)(4)(5). Regardless of the identity of the protein scaffold, site-specific gene modification generally requires the creation of individually tailored site-specific endonucleases that generate double-strand breaks (DSBs) at unique chromosomal targets.…”
mentioning
confidence: 99%
“…4A). [35][36][37][38] Fusion of the FokI endonuclease to a ZF or TALE DNA binding region, or the CRISPR-associated protein Cas9, enables these tools to induce site-specific double strand breaks (DSB). [37][38][39] Two features of FokI have made it an ideal enzyme to be used as a component of a site-specific nuclease.…”
Section: What Are the Rules Governingmentioning
confidence: 99%
“…[35][36][37][38] Fusion of the FokI endonuclease to a ZF or TALE DNA binding region, or the CRISPR-associated protein Cas9, enables these tools to induce site-specific double strand breaks (DSB). [37][38][39] Two features of FokI have made it an ideal enzyme to be used as a component of a site-specific nuclease. First, the wellcharacterized modular nature of the enzyme [40][41][42][43] has allowed just its catalytic domain to be fused with customizable DNA binding proteins such as zinc fingers and TALEs.…”
Section: What Are the Rules Governingmentioning
confidence: 99%
“…These TAL effectors in conjunction with the Fok1 nuclease (TALENs) have been shown to function similar to ZFNs [50,51] . The TALEN technology provides scientists with an increase in modularity allowing for the creation of many variants at little time and cost.…”
Section: A B Cmentioning
confidence: 99%